Prominent solubilizing effect of 2-hydroxypropyl-β-cyclodextrin on a new thiazolidine derivative (FPFS-410) with antidiabetic and lipid-lowering activities through inclusion complex formation

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 56, Issue 1-2, 2006, Pages 135-139

  Hara, Takumi ^a   Hirayama, Fumitoshi ^a   Arima, Hidetoshi ^a   Yamaguchi, Yoshihiro ^a   Uekama, Kaneto ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

2 hydroxypropyl cyclodextrin; FPFS 410; Inclusion complex; Solubility

Indexed keywords

EID: 47349093395     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-006-9074-5     Document Type: Conference Paper

References (13)

1. A.J. Scheen: Diabetes Metab. 27, 305 (2001).
2. C.H. Wang, R.D. Weisel, P.P. Liu, P.W.M. Fedak, and S. Verma: Circulation 107, 1350 (2003).
3. N. Norisada, H. Masuzaki, M. Fujimoto, G. Inoue, K. Hosoda, T. Hayashi, M. Watanabe, S. Muraoka, F. Yoneda, and K. Nakao: Metabolism 53, 1532 (2004).
4. V.J. Stella and R.A. Rajewski: Pharm. Res. 14, 556 (1997).
5. F. Hirayama and K. Uekama: Adv. Drug Deliv. Rev. 36, 125 (1999).
6. K. Uekama: Chem. Pharm. Bull. 52, 900 (2004).
7. T. Higuchi and K.A. Connors: Adv. Anal. Chem. Instrum. 4, 117 (1965).
8. T. Higuchi and H. Kristiansen: J. Pharm. Sci. 59, 1601 (1970).
9. R.L. Scott: Rec. Trav. Chim. 75, 787 (1956).
10. P. Job: Justus Liebigs Ann. Chem. 9, 113 (1928).
11. K. Miyake, T. Irie, H. Arima, F. Hirayama, K. Uekama, M. Hirano, and Y. Okamoto: Int. J. Pharm. 179, 237 (1999).
12. Y. Ikeda, S. Motoune, T. Matsuoka, H. Arima, F. Hirayama, and K. Uekama: J. Pharm. Sci. 91, 2390 (2002).
13. T. Loftsson, A. Magnúsdóttir, M. Má sson, and J.F. Sigurjónsdóttir: J. Pharm. Sci. 91, 2307 (2002).